Original ArticlePharmacognosy CommunicationsVol. 8 | Issue 4 | 2018 | pp. 158–164Open access
Interactive Antimicrobial Profiles of Astragalus membranaceus (Fisch.) Bunge Extracts and Conventional Antibiotics against Pathogenic and Non-pathogenic Gastrointestinal Bacteria
- 1,2,
- 3,4,
- 1,5*
- 1 School of Pharmacy and Pharmacology, Gold Coast Campus, Griffith University, Parklands Drive, Southport, Queensland 4222, AUSTRALIA.
- 2 College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, CHINA.
- 3 School of Environment and Science, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.
- 4 Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.
- 5 Menzies Health Institute Queensland, Quality Use of Medicines Network, Queensland 4222, AUSTRALIA.
Published in Pharmacognosy Communications
Correspondence: Matthew James Cheesman
School of Pharmacy and Pharmacology, Gold Coast Campus, Griffith University, Parklands Drive, Southport, Queensland 4222, AUSTRALIA.; Menzies Health Institute Queensland, Quality Use of Medicines Network, Queensland 4222, AUSTRALIA.
Email: m.cheesman@griffith.edu.au
Copyright: © 2018 Manuscript Technomedia. This is an open access article.
- Published:
- Oct 22, 2018
- DOI:
- 10.5530/pc.2018.4.33
How to cite
Lai, W., Cock, I. E., & Cheesman, M. J. (2018). Interactive Antimicrobial Profiles of Astragalus membranaceus (Fisch.) Bunge Extracts and Conventional Antibiotics against Pathogenic and Non-pathogenic Gastrointestinal Bacteria. Pharmacognosy Communications, 8(4), 158–164. https://doi.org/10.5530/pc.2018.4.33
Abstract
Background: The aim of this project was to investigate the efficacy of Astragalus membranaceus (Astragalus) extracts, alone and in combination with conventional antibiotics, against diarrhoea- and dysentery-causing pathogens, as well as against non-pathogenic gastrointestinal bacterial strains. The study sought to validate the chemotherapeutic potential of a traditional Chinese medicinal plant and to identify combinational thera- pies with increased efficacy compared to either the extracts or conven- tional antibiotics alone. Methods: Astragalus root powder was extracted with solvents of varying polarity and screened for inhibition of bacterial growth. Susceptibility was assessed by disc diffusion techniques, whilst the minimum inhibitory concentrations (MICs) were quantified by liquid dilution assays. To screen for combinatorial effects, the Astragalus root ex- tracts were combined with a range of conventional antibiotics and tested against each bacterial strain using liquid dilution assays. ΣFIC values were determined and used to determine the class of interaction. Results: Aque- ous Astragalus root extracts did not significantly inhibit the growth of the non-pathogenic or beneficial gut microflora bacteria E. cloacae, E. coli or E. faecalis, but possessed mild inhibitory activity against pathogenic A. fae- calis, A. hydrophila, B. cereus, S. newport and S. sonnei bacteria. Combi- nations of the Astragalus extracts and conventional antibiotics generally produced additive or indifferent interactions, indicating that they are safe to use concomitantly without compromising the efficacy of either compo- nent. Two cases of antagonistic combinations were detected against B. cereus and S. sonnei. Conclusion: Mild inhibition of 5 pathogenic bacteria occurred with aqueous Astragalus extracts, with a number of additive and antagonistic interactions arising when tested in combination with conven- tional antibiotics. Astragalus may be used safely in the presence of nor- mal gut bacteria and in most combinations with conventional antibiotics.
Keywords
Subject
Article metadata
| Title | Interactive Antimicrobial Profiles of Astragalus membranaceus (Fisch.) Bunge Extracts and Conventional Antibiotics against Pathogenic and Non-pathogenic Gastrointestinal Bacteria |
|---|---|
| Authors | Wenjing Lai; Ian Edwin Cock; Matthew James Cheesman |
| Affiliations | School of Pharmacy and Pharmacology, Gold Coast Campus, Griffith University, Parklands Drive, Southport, Queensland 4222, AUSTRALIA.; College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, CHINA.; School of Environment and Science, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.; Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.; Menzies Health Institute Queensland, Quality Use of Medicines Network, Queensland 4222, AUSTRALIA. |
| Corresponding author | m.cheesman@griffith.edu.au |
| Journal | Pharmacognosy Communications |
| Volume / Issue | Vol. 8, Issue 4 (2018) |
Also in this issue
- Editorialpp. 137
- Pharmacological and Phytochemical Updates on Pothos scandens Lpp. 138–145
- Alpinia cearulea (R.Br.) Benth Leaf Extracts Inhibit the Growth of a Panel of Bacterial Pathogenspp. 146–152
- Pseudomonas laurentiana sp. nov., an Mn(III)-oxidizing Bacterium Isolated from the St. Lawrence Estuarypp. 153–157
- The Janus Cornerpp. 165–169
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026